I bought today.
An 8% reduction in revenue GROWTH... resulted in a 22% haircut.
That's when you buy.
Quarterly earnings sequentially going up.
$2.83 $3.46 $3.78 $3.91 $ 4.22
A drop back to $3.75 next quarter won't be the end of the world for Biogen
That is a good argument except for the fact that recyclable copper has supplied about 50% of the total market (give or take a few percent) for the last 20 years.
That didn't stop the price of copper averaging more than $3 the last 10 years.
FCX proven copper reserves alone are more than 100 billion pounds. If you calculate $1 profit after mining and marketing costs. The company is worth $100B dollars without adding in all the other precious metals.
C'mon folks, very undervalued here.
ahh yes, we make up the rules as we go along ?
If that were to be the case, the options market would work differently. You didn't buy CELG options .
You can't have you cake and it it too.
perhaps shareholders will vote against it ?
If you didn't know it before, buying far outta the money call options is risky.
I've been trading biotech for 20 years now, and I've seen it all.
Why ? ... evidently for some promising future product. So I suppose CELG thinks they know something that Wall St doesn't know. I suppose both companies know what they are doing here.
That said, I'm still very skeptical off the previous RCPT buyout offer claims. If I remember correctly, as the story went.... Receptos management claimed to not be willing to accept any offers under $350, so that turned out to be totally bogus... no ?
I can imagine that might influence a speculator to buy a $250 call option.
I played it another way, being skeptical as I am. I sold Dec. $100 put options for $5.5. So I took much less risk than you, and made much more money.
Like I said, learn something here, you can start out by not being so greedy. Speculation is a loosing game most of the time.
I'm seeing that option trading at about $40. So you were expecting a company that is expected to loose about $6 per share in 2016 to trade over $290.
Why not just buy a GILD CELG AMGN or BIIB ?
Sorry I'm not too sympathetic, but learn something from this.
That makes you a rookie investor in love with your stock, watch that share price drop to $100 and your love affair might come to an end. There are 50 other promising biotech stocks out there with great pipelines also.
If rumor is true, this stock easy over $200, if false.... who knows. The share price could fall $125 to $60. It appears to be a promising pipeline, but years away from market.
Evidence is history based, due to the fact that the SEC requires M & A offers to be made public when an offer includes a premium. Do your DD folks.
I think this company is very legitimate, and I don't doubt that some other biotech companies would be interested in merging. That said, there is NO evidence of any offers.... by anyone .... PERIOD !
I'm pretty sure this will not end well for some stock buyers.
It's not the job of the company to fend off false rumors of this type. However, if the offers were true, it would be in the best interest of the shareholders if the so called offers were made public.
Really, three companies made legitimate offers for the company and not one report from RCPT or the suitors ?
Come on folks.
I'm trading this stock, just because it's easy to jump in and out and make some coin.
However, as to the Takeout rumors, I have serious doubts. Googling time after time, the only reference I can find is and activist shareholder is the one making the claims, that is quite self serving as we have seen from other activist shareholders of other companies. Any serious offer from any other company needs to be made public. That is material information, and shareholders have a right to know, especially offers of the magnitude this activist shareholder is claiming. If somebody can point to something more concrete, I'm all ears.
In fact, I would contend that an activist investor with that kind of information better be careful about his/her trading or it it would could well be viewed as insider information since Receptos never made those offers public information.
I have serious doubts about these rumors, but I'll trade interday again tomorrow.
My understanding that PSEC leveraged to higher interest rates, this issue should be going up if that the case....anybody ?
This issue acting very weak, however, I see nothing wrong with KMI. If you listen to the Cramer interview. He basically flipped from KMI to ETP on the basis of a fatter dividend yield.
Looks like KMI will probably touch the 200 day average soon... currently around $40, hopefully a bounce at the 200 day average.
Mr. Cramer is no idiot as some would imply. That said, I learned long ago not to pay much attention to his stock picks. He flip flops too much, and plays pump and dump. His general investment advice is however quite sound.
I've also learned to try to follow the big money on Wall St.
A couple months back, some large amount of KMI Jan. 2017 $50 call options were purchased for about $1.35, the same expiration $60 strike was sold to help finance the purchased call options. So for about a net $1.00 per share, the Jan. 2017 $50 calls were purchased. Currently the open interest is almost 400.000 call options at the $50 strike, representing 40 millions shares... and $40M dollars.
Stay with the big money.
BTW- I purchased the same Jan. 2017 $50 calls for about $1.28 per share. So far I've financed them by selling the same expiration $30 puts for about $1.10 each. When the KMI share price moves higher, I will sell the $60 calls against my $50 calls, as big money already modeled.
Check out the open interest for yourself.
Trades more like a Utility.
Looks like it's trading on TA more than anything, test of support at or near $42, where it broke out weeks ago.
I doubt it drops much below $42... if at all.